기사
Prodizen and O&N Clinic Announce GFC-Based Anti-Aging Treatment at the Daepimo Academic Conference
- 작성일 : 2025.12.19
- 조회수 : 9
[Medical Today = Reporter Minseok Choi] Prodizen presented on its GFC (Growth Factor Concentrate)-based anti-aging treatment at the Korean Society of Laser Dermatology and Hair Loss (hereinafter referred to as Dermatology) academic conference held at the Grand Intercontinental Parnas in Seoul on December 14.
On this day, Prodizen, along with Director Oh Myung-jun of O& Clinic, presented an academic presentation titled "Blood Concentrated Stem Cell Signaling: Stem Cell and GFC-Based Anti-Aging Treatment." This presentation reinterpreted aging and regenerative treatments from a regenerative medicine perspective, rather than a conventional aesthetic one, capturing the attention of medical professionals in the field.
Dr. Oh Myung-jun, who took the podium, defined the cause of aging not as a simple decrease in cell count, but rather as the collapse of the microenvironment (niche) where stem cells thrive and the decline in regenerative signaling. Dr. Oh emphasized, "The key to true anti-aging treatment is not transplanting cells from outside sources, but reawakening and activating dormant tissue regeneration signals."
During this process, Prodizen's proprietary platform, "GFC," was introduced as an alternative that overcomes the limitations of existing PRP (platelet-rich plasma) treatments. While existing PRPs focus solely on the simple "concentration rate" of platelets, GFC focuses on the "absolute amount of regenerative signals (Total Signal Mass)" administered, which determines the actual therapeutic effect.
According to the announcement, GFC is a highly concentrated solution containing quantitatively concentrated amounts of key regenerative signals, including stem cell-derived growth factors and cytokines. In fact, GFC contains more than six essential growth factors, promising benefits that encompass not only skin hydration and elasticity improvement, but also overall health recovery.
The presentation was attended by many medical professionals, demonstrating strong interest in the GFC procedure. Following the presentation, a Q&A session followed, and at the Prodizen exhibition booth, inquiries regarding clinical applications and specific protocols continued. In particular, in-depth discussions were held regarding the potential of GFC, extending beyond localized skin improvement to full-body anti-aging.
A Prodizen official said, “This academic conference is significant in that it goes beyond a simple technology introduction and shares the new medical trend of ‘signal-based regenerative therapy’ with clinical settings.” He added, “We will continue to solidify our position as a unique blood-based regenerative platform company through domestic and international academic activities and collaboration with medical professionals.”
Medical Today Reporter Choi Min-seok (press@mdtoday.co.kr)
다음글